Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingPhase 12026-09-01NCT07586618

3 results · Page 1 of 1

Swipe the table sideways for more columns.

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital ColoradoAuroraUnited States312
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Cincinnati Children's Hospital Medical CenterCincinnatiUnited States405
Cook Children's Medical CenterFort WorthUnited States111
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Riley Children's HosptialIndianapolisUnited States1
Texas Children's HospitalHoustonUnited States187